Cancerous tumors are composed of cells that may look the same but are in fact incredibly diverse. Mutations and changes in gene activity give rise to competing sub-populations of tumor cells with...
In a year overshadowed by the coronavirus pandemic, the OHSU Knight Cancer Institute's people adapted and accomplished many great things. From basic research, to patient care, to impact in the...
OHSU scientists have shown how it’s possible to obtain detailed views of breast cancer gene activity from preserved tumor samples more than a decade old. The researchers say their RNA sequencing...
From basic research, to patient care, to impact in the community, the OHSU Knight Cancer Institute has a mission to end cancer as we know it. Here’s a look back at a year of...
Researchers have uncovered a potential drug target for stopping castration-resistant prostate tumors – the second leading cause of cancer death in the U.S. For decades, drug development for...
Serving Oregonians. Delivering discoveries. Developing talented clinicians and scientists. Leading the way. Here's a look at the accomplishments of the people at the Knight Cancer Institute. They...
(OHSU/Joe Rojas-Burke) Ironworkers placed the final steel beam onto the Knight Cancer Research Building on Monday. And in the "topping out" tradition, members of Ironworkers Local 29 signed the...
Finding new treatment targets for aggressive prostate cancer, lymphoma and leukemia. Visualizing how breast tumors grow resistant to drug therapy. Using mobile phone sensors to track symptoms...
Knight Cancer Institute researchers Brian Druker, M.D., and Michael Heinrich, M.D., are among the "world's most influential scientific minds," according to the annual list produced by Thomson...